UNSPSC 51391735: Theodrenaline

This classification denotes a cardiotonic agent with the molecular formula C17H21N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RW8PD99T8G, chemically known as 7-(2-(2-hydroxy-2-(3,4-dihydroxyphenyl)ethylamino)ethyl)theophylline but generally known as theodrenaline, which bears US NIH Compound Identifier 71857. European Medicines Agency schedules Theodrenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10963MIG. The term THEODRENALINE is an International Non-Proprietary Name.

UNSPSC 51391735 Theodrenaline is a Commodity code under which state and local governments procure pharmaceutical products and related health intervention systems, specifically naloxone and drug deactivation equipment for emergency response and community health programs. The scope of work encompasses the supply and delivery of opioid antagonists and controlled-substance disposal systems to support public health initiatives, with vendors typically responsible for logistics, quarterly or periodic fulfillment schedules, and compliance with workplace and federal requirements. Issuing bodies include county health departments and state health agencies; recent activity shows Seminole County, Florida and the Texas Health and Human Services Commission soliciting under this code, representing both direct-purchase and vendor-capability exploration mechanisms at the county and state level.

Activity under this code is geographically sparse. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, requiring quarterly delivery to the Seminole County Community Health Building in Sanford; the contract carries a two-year initial term with a one-year renewal option and includes FEMA funding contingencies. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, as a preliminary market-intelligence vehicle to evaluate vendor capabilities for direct-to-manufacturer prescription programs rather than a formal competitive solicitation. The narrow geographic footprint and small number of recent postings signal limited procurement velocity under this code at present.